Data / Form D filings / Regado Biosciences Inc
Regado Biosciences Inc: Form D filings
Regado Biosciences Inc, a biotechnology company in Basking Ridge, NJ, filed 7 Form D notices with the SEC between 2010 and 2014. The latest, on February 25, 2014, reports $20 million sold of a $20 million offering to 15 investors.
Find out what Regado Biosciences Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 MOUNTAIN VIEW BOULEVARD, Basking Ridge, NJ, 07920
- Phone
- (908) 580-2111
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1311596
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 25, 2014 | New notice | $20,000,000 | $20,000,000 | $0 | 15 | Feb 5, 2014 | sec.gov |
| Jan 17, 2013 | New notice | $50,780,221 | $22,634,958 | $28,145,263 | 8 | Dec 18, 2012 | sec.gov |
| May 21, 2012 | New notice | $13,561,080 | $6,780,540 | $6,780,540 | 6 | May 3, 2012 | sec.gov |
| Jul 1, 2011 | New notice | $11,599,999 | $11,599,999 | $0 | 8 | May 25, 2011 | sec.gov |
| Jul 1, 2011 | Amendment | $40,000,000 | $40,000,000 | $0 | 8 | Mar 30, 2010 | sec.gov |
| Jun 30, 2011 | Amendment | $26,149,167 | $26,149,167 | $0 | 8 | Dec 17, 2009 | sec.gov |
| Jan 5, 2010 | New notice | $14,549,167 | $14,549,167 | $0 | 8 | Dec 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jesse J. Treu | Director | |
| Michael J. Mendelsohn | Director | |
| Pierre J. Legault | Director | |
| Raphael Jefferson Wisniewski | Director | |
| P. Sherrill Neff | Director | |
| B. Jefferson Clark | Director | |
| Chris J. Courts | Executive Officer | |
| Dennis J. Podlesak | Director | |
| Michael J. Metzger | Executive Officer | |
| Anton J. Gopka | Director | |
| David J. Mazzo | Executive Officer, Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Feb 24, 2014 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Regado Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.